Tag: Kalvista Pharmaceuticals Inc

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Kalvista Pharmaceuticals Inc

The Vanguard Group Inc. Has $6.56 Million Holding in Kalvista Pharmaceuticals Inc (KALV)

Added to Collection on: 2019-05-19 05:45:00

Tags for this article:

Life Sciences
Financial regulation
Short
Biotechnology
Pharmaceutical industry
Specialty drugs
Kalvista Pharmaceuticals Inc

Click the tags to see associated articles and topics

View Article Details
Vanguard Group Inc. Boosts Holdings in Kalvista Pharmaceuticals Inc (NASDAQ:KALV)

Added to Collection on: 2019-10-21 19:37:30

Tags for this article:

Life Sciences
Industry economics)
Biotechnology
Kalvista Pharmaceuticals Inc
NASDAQ COMPOSITE INDEX

Click the tags to see associated articles and topics

View Article Details
Tower Research Capital LLC TRC Increases Stock Position in Kalvista Pharmaceuticals Inc ...

Added to Collection on: 2019-12-25 08:22:30

Tags for this article:

Financial markets
Finance
Financial economics
Corporate finance
Stock
Stock market
Short
Pfizer
Tower Research Capital Llc
Kalvista Pharmaceuticals Inc

Click the tags to see associated articles and topics

View Article Details
Millennium Management LLC Trims Stock Holdings in Kalvista Pharmaceuticals Inc (NASDAQ:KALV)

Added to Collection on: 2020-01-01 19:15:00

Tags for this article:

Financial markets
Finance
Financial economics
Financial regulation
Short
Stock
Bausch Health
Kalvista Pharmaceuticals Inc
Millennium Management Llc

Click the tags to see associated articles and topics

View Article Details
Millennium Management LLC Has $164000 Stake in Kalvista Pharmaceuticals Inc (NASDAQ:KALV)

Added to Collection on: 2020-01-16 13:26:15

Tags for this article:

Financial markets
Finance
Financial economics
Corporate finance
Stock
Stock market
Short
Price?earnings ratio
Kalvista Pharmaceuticals Inc
Millennium Management Llc

Click the tags to see associated articles and topics

View Article Details
Millennium Management LLC Sells 372406 Shares of Kalvista Pharmaceuticals Inc (NASDAQ:KALV)

Added to Collection on: 2020-01-24 07:26:15

Tags for this article:

Life Sciences
Financial regulation
Short
Biotechnology
Economy
Specialty drugs
Kalvista Pharmaceuticals Inc

Click the tags to see associated articles and topics

View Article Details
KalVista Pharmaceuticals Announces Pricing of an Upsized $193.5 Million Public Offering of ...

Added to Collection on: 2021-02-11 02:48:45

Tags for this article:

Initial public offering
Financial markets
Finance
Financial economics
Money
Prospectus
Forward-looking statement
Shelf registration
Registration statement
Public offering
U.S. Securities and Exchange Commission
United States Securities Regulation
Kalvista Pharmaceuticals Inc

Click the tags to see associated articles and topics

View Article Details
KalVista Pharmaceuticals Announces the Closing of its Upsized Public Offering of Common Stock ...

Added to Collection on: 2021-02-16 21:00:00

Tags for this article:

Initial public offering
Finance
Financial economics
Financial markets
Prospectus
Forward-looking statement
Public offering
U.S. Securities and Exchange Commission
Stifel
Hereditary angioedema
Registration statement
Kalvista Pharmaceuticals Inc

Click the tags to see associated articles and topics

View Article Details
DAFNA Capital Management LLC Buys Galapagos NV, Cassava Sciences Inc, Dicerna ...

Added to Collection on: 2021-02-16 23:37:30

Tags for this article:

Financial markets
Financial economics
Corporate finance
Stock
Stock market
Dafna
Finance
Dicerna Pharmaceuticals Inc
Kalvista Pharmaceuticals Inc
Immunomedics Inc.
BioCryst Pharmaceuticals Inc.
Kinnate Biopharma Inc.
Fate Therapeutics Inc
Cassava Sciences Inc.
Venus Concept Inc.
Dafna Capital Management Llc
Galapagos NV

Click the tags to see associated articles and topics

View Article Details
KalVista Pharmaceuticals (NASDAQ:KALV) Rating Lowered to Sell at Zacks Investment Research

Added to Collection on: 2022-03-12 12:09:32

Tags for this article:

Life Sciences
Financial markets
Financial economics
Corporate finance
Stock
Stock market
Specialty drugs
Kalvista Pharmaceuticals Inc
Carbylan Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details